5.26 USD
-0.04 (-0.75%)
5.32 USD
+0.06 (+1.14%)
Overall AVXL gets a fundamental rating of 3 out of 10. We evaluated AVXL against 525 industry peers in the Biotechnology industry. AVXL has a great financial health rating, but its profitability evaluates not so good. AVXL is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
- In the past year AVXL has reported negative net income.
- In the past year AVXL has reported a negative cash flow from operations.
- AVXL had negative earnings in each of the past 5 years.
- In the past 5 years AVXL always reported negative operating cash flow.
1.2 Ratios
- AVXL's Return On Assets of -44.67% is in line compared to the rest of the industry. AVXL outperforms 55.62% of its industry peers.
- The Return On Equity of AVXL (-48.89%) is better than 67.24% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -44.67% | ||
| ROE | -48.89% | ||
| ROIC | N/A |
ROA(3y)-35.72%
ROA(5y)-32.41%
ROE(3y)-39.37%
ROE(5y)-35.39%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- The Profit Margin and Operating Margin and Gross Margin are not available for AVXL so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
- Compared to 1 year ago, AVXL has more shares outstanding
- Compared to 5 years ago, AVXL has more shares outstanding
- AVXL has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
- AVXL has an Altman-Z score of 26.07. This indicates that AVXL is financially healthy and has little risk of bankruptcy at the moment.
- AVXL has a better Altman-Z score (26.07) than 90.86% of its industry peers.
- AVXL has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 26.07 |
ROIC/WACCN/A
WACCN/A
2.3 Liquidity
- AVXL has a Current Ratio of 11.60. This indicates that AVXL is financially healthy and has no problem in meeting its short term obligations.
- The Current ratio of AVXL (11.60) is better than 86.29% of its industry peers.
- AVXL has a Quick Ratio of 11.60. This indicates that AVXL is financially healthy and has no problem in meeting its short term obligations.
- AVXL has a Quick ratio of 11.60. This is amongst the best in the industry. AVXL outperforms 86.29% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 11.6 | ||
| Quick Ratio | 11.6 |
3. Growth
3.1 Past
- AVXL shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -3.85%.
EPS 1Y (TTM)-3.85%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%21.43%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
3.2 Future
- AVXL is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 63.31% yearly.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y9.33%
EPS Next 2Y109.74%
EPS Next 3Y106.31%
EPS Next 5Y63.31%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
- AVXL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
- Also next year AVXL is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- A more expensive valuation may be justified as AVXL's earnings are expected to grow with 106.31% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y109.74%
EPS Next 3Y106.31%
5. Dividend
5.1 Amount
- No dividends for AVXL!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
ANAVEX LIFE SCIENCES CORP / AVXL FAQ
Can you provide the ChartMill fundamental rating for ANAVEX LIFE SCIENCES CORP?
ChartMill assigns a fundamental rating of 3 / 10 to AVXL.
What is the valuation status for AVXL stock?
ChartMill assigns a valuation rating of 1 / 10 to ANAVEX LIFE SCIENCES CORP (AVXL). This can be considered as Overvalued.
What is the profitability of AVXL stock?
ANAVEX LIFE SCIENCES CORP (AVXL) has a profitability rating of 1 / 10.
What is the expected EPS growth for ANAVEX LIFE SCIENCES CORP (AVXL) stock?
The Earnings per Share (EPS) of ANAVEX LIFE SCIENCES CORP (AVXL) is expected to grow by 9.33% in the next year.